Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Clorox ( (CLX) ) is now available.
On Feb. 3, 2026, Clorox reported that second-quarter fiscal 2026 net sales for the period ended Dec. 31, 2025 slipped 1% to $1.67 billion, with organic sales down 1% as lower consumption more than offset shipments pulled forward in some businesses. Gross margin contracted by 60 basis points to 43.2% on higher manufacturing and logistics costs, and diluted EPS fell 16% to $1.29, while adjusted EPS declined 10% to $1.39, although operating cash flow for the year to date edged up 1% to $404 million. Segment performance was mixed, with modest sales growth but lower profitability in Health and Wellness, a sharp EBIT decline in Household on weaker demand and cost pressures, flat-to-better profitability in Lifestyle despite softer sales, and strong sales and EBIT growth internationally. Strategically, Clorox highlighted a definitive deal to acquire GOJO Industries and its Purell brand, the completion of the final phase of its U.S. ERP rollout, and a slate of new product launches, all underpinning management’s decision to reaffirm full-year guidance for 2026, even as earlier order-fulfillment issues and an intentional ERP-related inventory build and drawdown are expected to weigh heavily on reported sales and earnings, positioning results toward the lower end of its forecast ranges.
The most recent analyst rating on (CLX) stock is a Hold with a $142.00 price target. To see the full list of analyst forecasts on Clorox stock, see the CLX Stock Forecast page.
Spark’s Take on CLX Stock
According to Spark, TipRanks’ AI Analyst, CLX is a Neutral.
The score is primarily held back by balance-sheet risk (high leverage and negative equity) and recent sales/FCF declines. Offsetting factors include solid profitability, improving technical momentum, a reasonable P/E with a strong dividend, and a mixed-but-improving outlook as ERP disruptions fade and innovation ramps.
To see Spark’s full report on CLX stock, click here.
More about Clorox
The Clorox Company is a U.S.-based consumer products manufacturer best known for its namesake cleaning and disinfecting brands, along with a portfolio that spans health and wellness, household, lifestyle and international products sold to consumers and professional customers worldwide. The company is increasingly focused on health and hygiene, recently moving to add GOJO Industries’ Purell brand, and is investing heavily in digital transformation, including a major enterprise resource planning (ERP) upgrade in the U.S.
Average Trading Volume: 2,341,461
Technical Sentiment Signal: Sell
Current Market Cap: $13.76B
Learn more about CLX stock on TipRanks’ Stock Analysis page.